Professor Hutmacher is director of the Centre in Regenerative Medicine at the ARC Training Centre in Additive Biomanufacturing where, as at IHBI, he has built a multidisciplinary research team including engineers, cell biologists, polymer chemists, clinicians, and veterinary surgeons.
His ability to transcend traditional disciplinary boundaries and initiate and nurture research and develop international educational programs across different disciplines has brought Professor Hutmacher a worldwide reputation as a pioneer in the field of biomaterials and tissue engineering regenerative medicine.
Professor Hutmacher's thorough understanding of the status of the biomedical engineering field, and clear vision of the needs for the 21st century for this exciting and rapidly evolving multidisciplinary research field has seen traditional scientific/academic outputs as well as pivotal commercialization outcomes.
He has published more than 300 journal articles, edited 14 books, 40 book chapters and more than 500 conference abstracts. His body of research has had more than 20,000 citations, has an h-index of 68 and 10 patents and four spin-off companies.
Originally trained as an engineer, Professor Hutmacher is one of the few academics in the field of biomaterials/tissue engineering to have taken a research program from fundamental research through to clinical application utilizing research in-vitro, in-vivo, preclinical models and clinical trials.
He joins a small group of the early pioneers who started the biomaterials field in the 1970s such as Michael Sefton (2016), Nicholas Peppas (2015), James Anderson (2014).
The achievement of this prestigious award is particularly pleasing as Professor Hutmacher began his academic career only 20 years ago. He will receive the award in Athens in September.
Provided by Queensland University of Technology
This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.